Friedlander et al. [7] |
Pancreatic adenocarcinoma |
Pancreas and regional lymph nodes |
1.8 Gy × 28 (50.4 Gy) |
Gemcitabine (40 mg/m2 biweekly and concurrently with radiation, followed by 1,000 mg/m2 weekly for 3 weeks per month) |
39 days |
3 months |
Tenderness of rectus muscles, mild rash, elevated CK |
Yes |
Increased signal in the subcutaneous tissue of the anterior abdominal wall (MRI) |
Corticosteroids |
Complete resolution, no recurrence after steroid tapering |
Not reported |
|
Ganem et al. [22] |
Squamous cell carcinoma of the lung |
Pelvis |
3 Gy × 11 (33 Gy) |
Gemcitabine (1,000 mg/m2 on days 1, 8, 15) and cisplatin (100 mg/m2 on day 15) |
1.5 months |
5 months |
Right buttock pain |
Yes |
Hypersignal and edema on gluteal soft tissue (MRI) |
Oral opiates, antibiotics, steroids |
Alleviation over the course of 3 months |
Not reported |
|
Graf et al. [16] |
NSCLC and anal cancer, history of dermatomyositis |
Pelvis |
Not reported |
5-FU and MMC given with pelvic RT for anal cancer, carboplatin and gemcitabine (dosage not given) |
2 months |
4 months |
Erythema, swelling, warmth, and tenderness of the buttocks and groin area |
Yes |
High signal in the bilateral gluteal maximus, quadratus femoris, adductor magnus, obturator externus and right iliopsoas muscles (MRI), elevated CK |
Prednisone and opiate analgesia |
Gradual improvement with steroids |
Not reported |
|
Grover et al. [5] |
Adenocarcinoma and neuroendocrine neoplasm, unknown primary |
Left hip and left acromion |
3 Gy × 10 (30 Gy) |
Gemcitabine (1,250 mg/m2) and carboplatin (AUC 5) |
2 weeks |
4 weeks |
Worsening pain in left shoulder and hip |
Yes |
Soft tissue edema of the muscles adjacent to the left acromion and the left hip (MRI) |
Narcotics |
Pain resolved 5 months after radiotherapy |
Gemcitabine therapy continued |
|
Horan et al. [23] |
NSCLC |
Lung |
3 Gy × 8 (24 Gy) |
Gemcitabine (1,000 mg/m2, weekly) |
2 months |
∼13 weeks |
Pain and swelling of the right pectoralis major, biopsy proven muscle necrosis |
Yes |
Thickening of right pectoralis major muscle (CT) |
Analgesics |
Symptoms gradually declined when gemcitabine was stopped |
Gemcitabine re-challenge, no further symptoms |
|
Jeter et al. [11] |
Pancreatic adenocarcinoma |
Pancreas |
1.8 Gy × 28 (50.4 Gy) |
Gemcitabine (1,000 mg/m2 one dose; followed by 750 mg/m2 weekly for 9 months) |
3 weeks |
3 months |
Abdominal wall tenderness and erythema |
Yes |
Subcutaneous fat stranding and decreased density of rectus muscles in radiation portal (CT) |
Ibuprofen |
Symptoms responsive to ibuprofen |
Gemcitabine re-challenge, no further symptoms |
|
Lock et al. [24] |
Hepatic adenocarcinoma |
Liver |
2.94 Gy × 15 (44.1 Gy) |
Gemcitabine (1,000 mg/m2 for days 1 and 8 for a 3-week cycle) |
8 weeks |
18 weeks |
Abdominal discomfort with induration; overlying skin erythema |
Yes |
Enhancement of abdominal muscles with thickening (MRI) |
Ibuprofen, vitamin E, and vitamin C |
Gradual resolution over the course of 6 weeks |
Gemcitabine was continued, reduction of symptoms |
|
Miura et al. [25]a
|
NSCLC |
Right hip |
2 Gy × 25 (50 Gy) |
Concurrent cisplatin (80 mg/m2 day 1) and vinorelbine (20 mg/m2, days 1, 8, and 15) followed by gemcitabine (800 mg/m2 biweekly) |
1 month |
3 months |
Right thigh pain |
N/A |
Edema within right thigh muscles (MRI) |
Analgesics |
Gradual resolution of symptoms |
Yes (unknown regimen) |